XML 163 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Schedule of Benefit from Income Taxes

The components of the benefit from income taxes consist of the following (in thousands):

 

   Year Ended December 31, 
   2024   2023 
Deferred:        
Deferred benefit  $2,585   $5,776 
Deferred tax asset valuation allowance   (2,585)   (5,776)
Total benefit from income taxes  $
   $
 
Schedule of Effective Tax Rate to the Statutory Federal Income Tax Rate

A reconciliation of the Company’s effective tax rate to the statutory federal income tax rate is as follows:

 

   Year Ended December 31, 
   2024   2023 
Tax benefit at statutory rate   21.0%   21.0%
State income taxes, net of federal benefit   0.2%   1.5%
Permanent items   (0.6)%   (11.8)%
Federal business credits   (0.8)%   (0.4)%
Valuation allowance   (14.9)%   (10.3)%
Other   (4.9)%   
%
Effective income tax rate   
%   
%
Schedule of Deferred Tax Assets and Liabilities

The components of deferred tax assets and liabilities consisted of the following (in thousands):

 

   Year Ended December 31, 
   2024   2023 
Deferred tax assets:        
Net operating loss carryforwards  $43,283   $41,156 
Startup/organization costs   3,130    3,865 
Tax credits   1,828    1,960 
Capitalized research and development   3,720    
 
Other   1,251    3,685 
Total deferred tax assets   53,212    50,666 
Valuation allowance   (52,779)   (50,228)
Net total deferred tax assets   433    438 
Deferred tax liabilities:          
Derivative instruments   (194)   (418)
Other   (239)   (20)
Total deferred tax liabilities   (433)   (438)
Net deferred tax assets  $
   $
 
Schedule of Tax Contingencies

The reconciliation of tax contingencies is as follows (in thousands):

 

   Year Ended December 31, 
   2024   2023 
Gross tax contingencies - January 1  $516   $545 
Gross decreases for current year   
    (29)
Gross increases for current year   964    
 
Gross tax contingencies - December 31  $1,480   $516